Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 113320631000001110 | Doxorubicin (liposomal) (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 113320641000001115 | Doxorubicin (liposomal) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Doxorubicin (liposomal) | Is a | Medicinal product containing anthracycline and acting as antineoplastic agent (product) | true | Inferred relationship | Existential restriction modifier | ||
| Doxorubicin (liposomal) | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Doxorubicin (liposomal) 50mg powder and solvent for suspension for injection vials | Is a | True | Doxorubicin (liposomal) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR